SCHEMBL9474742

SCHEMBL9474742

O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(Cl)c(Cl)c21.[NaH].[NaH]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.58
HPGD P15428 3/20 0.58
MAPT P10636 3/20 0.58
SMAD3 P84022 2/20 0.58
MEN1 O00255 2/20 0.58
HTT P42858 2/20 0.58
KMT2A Q03164 2/20 0.58
RECQL P46063 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
CYP2C19 P33261 1/20 0.58
BLM P54132 1/20 0.58
PRMT1 Q99873 1/20 0.58
ACE2 Q9BYF1 1/20 0.58
ALDH1A1 P00352 3/20 0.55
ALOX12 P18054 2/20 0.55
BRCA1 P38398 2/20 0.55
HSD17B10 Q99714 2/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
DHFR P00374 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL273427 0.99 FTO (0.59) FTOHPGDMAPTSMAD3MEN1
SCHEMBL3625220 0.87 FTO (0.58) FTOHPGDMAPTSMAD3MEN1
SCHEMBL4632262 0.87 MEN1 (0.49) FTOHPGDMAPTSMAD3MEN1
SCHEMBL5694289 0.86 FTO (0.46) FTOHPGDMAPTSMAD3MEN1
SCHEMBL1703820 0.86 MAPT (0.59) FTOHPGDMAPTSMAD3MEN1
SCHEMBL1682613 0.85 FTO (0.63) FTOHPGDMAPTSMAD3MEN1
SCHEMBL17515090 0.84 ALDH1A1 (0.55) FTOHPGDMAPTSMAD3MEN1
SCHEMBL79627 0.83 HPGD (0.63) FTOHPGDMAPTSMAD3MEN1
SCHEMBL9844359 0.82 FTO (0.43) FTOHPGDMAPTSMAD3MEN1
SCHEMBL1209657 0.82 FTO (0.43) FTOHPGDMAPTSMAD3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170000908-A1 A MICELLAR PARTICLE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2017-01-05 US claimed
WO-2015080668-A1 A MICELLAR PARTICLE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-04 WO claimed
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS ICU MEDICAL INC (US) 2026-05-21 US disclosed
US-12521309-B2 Compositions and devices for containing medical fluids ICU MEDICAL, INC. (US) 2026-01-13 US disclosed
US-20220105001-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS ICU MEDICAL, INC. 2022-04-07 US disclosed
US-20170000908-A1 A MICELLAR PARTICLE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2017-01-05 US disclosed
WO-2015080668-A1 A MICELLAR PARTICLE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-04 WO disclosed
US-5274086-A A xanthene derivative KIKKOMAN CORPORATION (JP) 1993-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS TFEB, LAGE3, RICTOR FTO 20/4885HPGD 1998/4885MAPT 97/4885
US-20170000908-A1 A MICELLAR PARTICLE CHMP4B, NPC1L1, CAPG FTO 2186/4885HPGD 4520/4885MAPT 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.